Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Botrytis cinerea T4 strain:T4

ABSTRACT: Botryotinia fuckeliana strain T4 genome sequencing, draft assembly version 2

PROVIDER: PRJNA162725 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ALOC01.dat.gz	Other
	ALOC01.fasta.gz	Fasta.gz
	ALOC01.master.dat	Other
	ALOC01.dat.gz	Other

Items per page:

1 - 4 of 4

Similar Datasets

Botrytis cinerea T4

Project description:Botryotinia fuckeliana isolate T4 genome sequencing

| PRJNA64593 | ENA

Genome update of Botrytis cinerea strains B05.10 and T4.

Project description:We report here an update of the Botrytis cinerea strains B05.10 and T4 genomes, as well as an automated preliminary gene structure annotation. High-coverage de novo assemblies and reference-based alignments led to a correction of wrong base calls, elimination of sequence gaps, and improved joining of contigs. The new assemblies have substantially lower numbers of scaffolds and a concomitant increase in the N(50).The list of protein-coding genes was generated using the evidence-driven gene predictor Augustus, with expressed sequence tag evidence and RNA-Seq data as input.

| S-EPMC3486023 | biostudies-literature

Bacillus subtilis strain:T4

Project description:Bacillus subtilis strain:T4 Genome sequencing and assembly

| PRJNA505926 | ENA

Methylocella tundrae strain:T4

Project description:Methylocella tundrae strain:T4 Genome sequencing and assembly

| PRJNA521328 | ENA

Analysis of botrytis cinerea mycelium proteins

Project description:Comparison of Botrytis cinerea wild-type B.05.10 and T4 strains using label-free nUPLC-MSE and 2-DE approaches. B. cinerea strain mycelium were grown in synthetic minimal medium-modified Czapeck-Dox. Protein extracts were obtained from pulverized mycelium using TCA-phenol method. Acquired spectra were internally calibrated with peptides from trypsin 180 autolysis (M+H+=842.509,M+H+=2211.104) with an m/z precision of ±20 ppm. A combined search (PMF and MS/MS) was performed with GPS ExplorerTM software v3.5 (Applied Biosystems) over non-redundant NCBI databases using the MASCOT search engine. The database search utilized the following parameters: taxonomy restrictions to Fungi (06.17.2011), one missed cleavage sites, 100 ppm mass tolerance in MS and 0.5 Da for MS/MS data, cysteine carbamidomethylation as a fixed modification, and methionine oxidation as a variable modification. The confidence in the peptide mass fingerprinting matches (p<0.05) was based on the MOWSE score.

2013-05-02 | PXD000165 | Pride

Klebsiella pneumoniae strain:T4

Project description:Klebsiella pneumoniae strain:T4 Genome sequencing

| PRJNA509538 | ENA

Flavobacterium anhuiense strain:T4

Project description:Flavobacterium anhuiense strain:T4 Genome sequencing

| PRJNA776699 | ENA

Pectobacterium odoriferum strain:T4

Project description:Pectobacterium carotovorum subsp. odoriferum strain T4 Genome sequencing and assembly

| PRJNA360220 | ENA

K5 capsule and lipopolysaccharide are important in resistance to T4 phage attack in probiotic E. coli strain Nissle 1917

Project description:Rapidly growing antibiotic resistance among gastrointestinal pathogens, and the ability of antibiotics to induce the virulence of these pathogens makes it increasingly difficult to rely on antibiotics to treat gastrointestinal infections. The probiotic E. coli strain Nissle 1917 (EcN) is the active component of the pharmaceutical preparation Mutaflor® and has been successfully used in the treatment of gastrointestinal disorders. Gut bacteriophages are dominant players in maintaining the microbial homeostasis in the gut, however, their interaction with incoming probiotic bacteria remains to be at conception. The presence of bacteriophages in the gut makes it inevitable for any probiotic bacteria to be phage resistant, in order to survive and successfully colonize the gut. This study addresses the phage resistance of EcN, specifically against lytic T4 phage infection. From various experiments we could show that i) EcN is resistant towards T4 phage infection, ii) EcN’s K5 polysaccharide capsule plays a crucial role in T4 phage resistance and iii) EcN’s lipopolysaccharide (LPS) inactivates T4 phages and notably, treatment with the antibiotic polymyxin B which neutralizes the LPS destroyed the phage inactivation ability of isolated LPS from EcN. Our results further indicate that N-acetylglucosamine at the distal end of O6 antigen in EcN’s LPS could be the interacting partner with T4 phages. From our findings, we have reported for the first time, the role of EcN’s K5 capsule and LPS in its defense against T4 phages. In addition, by inactivating the T4 phages, EcN also protects E. coli K-12 strains from phage infection in tri-culture experiments. The combination of the identified properties is not found in other tested commensal E. coli strains. Furthermore, our research highlights phage resistance as an additional safety feature of EcN, a clinically successful probiotic E. coli strain.

2019-08-27 | GSE135946 | GEO

Enterococcus faecalis EnGen0333 strain:T4

Project description:Enterococcus faecalis EnGen0333 strain:T4 Genome sequencing and assembly

| PRJNA158749 | ENA